Cash to Monthly Cash Expenses Rato Amicus Therapeutics, Inc., a biopharmaceutical company that develops drugs for the treatment of various diseases, including Parkinson's disease. Anicus Therapeutice reported the following financial data On thousands for the recent year For Years Ended December 31 Year Year 2 Year 1 Cash and cash equivalents 179.749 349,060 $187,026 Net cash flows from operations (299,955) (213,695) (156,147 a. Determine the monthly can expens for Year Year 2 nd Year 1 (in thousands). Round to one decimal place Year 3 per month Year per month Year 1 per month Determine the roof caute monthly call center for Year 3, Yew and Year of December 31. Round to one decimal place Year months Year 2 months Year 1 months 6. Based on (a) and (b), which of the following statements is correct 1. Amicus has been able to support its operations by uing additional stock. However, its negative cash flows have increased from Year 1 to Year 2. Amicus has been able to support is operations generating positive cash flows. Its positive cash flows have increased from Year 1 to Year 3. Amicusas been able to support its operations generating positive cash flows. However, the cash flow generated are used to purchase short term investment 1